AbbVie | ABBV - Current Assets

Stock Price
225.51
Daily Change
2.50 1.12%
Monthly
2.42%
Yearly
18.60%
Q1 Forecast
216.14

AbbVie reported $28.54B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 28.54B 722M Sep/2025
Abbott USD 24.84B 371M Sep/2025
ALKERMES USD 1.74B 106.38M Sep/2025
Amgen USD 27.88B 1.15B Sep/2025
AstraZeneca USD 29.94B 1B Sep/2025
Biogen USD 8.94B 968.9M Sep/2025
BioMarin Pharmaceutical USD 3.85B 49.21M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Eisai JPY 790.7B 27.55B Sep/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
Gilead Sciences USD 18.84B 4.12B Sep/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
J&J USD 54.61B 113M Sep/2025
Medtronic USD 23.22B 591M Jun/2025
Merck USD 47.56B 10.49B Sep/2025
Neurocrine Biosciences USD 2.16B 409.5M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Pacira USD 562.75M 182.86M Sep/2025
Perrigo USD 2.88B 264.2M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Regeneron Pharmaceuticals USD 17.98B 1.12B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
UCB EUR 4.79B 1.47B Dec/2024
Ultragenyx Pharmaceutical USD 643.21M 76.58M Sep/2025
United Therapeutics USD 3.49B 332.9M Sep/2025
Vertex Pharmaceuticals USD 10.57B 141.7M Sep/2025
Zoetis USD 6.58B 660M Sep/2025